SecBot SecBot

APLM

Apollomics Inc.
Nasdaq· Pharmaceutical Preparations· CIK 0001944885 Biotech & Drug Discovery
$20.69 −1.15 (−5.27%)
Oct 26 4:00 PM ET · prev $21.84
Market cap
$63.7M
Micro cap
1 year
−10.0%
from $23.00 · Oct 27
30 days
−13.2%
from $23.84
52-week range
$11.61–28.01
−26% from high · low Oct 30
Avg volume 20D
7.8K
Oct 26 spike 72.0K
Short interest
5.7K
≈0.2% of shares · +1.6%
Days to cover
1.0
at average volume
Insider net
+$8.3M
3 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 4 bullish oldest → newest, height = score
Avg score ·High conf. 4/4
Strongest BULLISH Three C-suite insiders at Apollomics Inc. (APLM) collectively purchased $2.25M in open-market stock at…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $8.3M. No open-market sales.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest +1.6% to 5.7K shares. 1.0 days to cover, ≈0.2% of shares.

  • TrendDOWNTREND

    12% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGNEAR_EXIT2$42.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2024
Recent actions
DateFirmActionRating
May 8, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Apr 1, 2024EF Hutton
MAINTAIN
MAINTAINBuy
Apr 1, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Nov 20, 2023HC Wainwright & Co.
REITERATE
REITERATEBuy
Oct 3, 2023HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Jun 5, 2023HC Wainwright & Co.
REITERATE
REITERATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jul 17, 2026
Trading halt
Halt Resumed: APLM — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-07-17T13:47:39.000Z | Resumed 2026-07-17T13:52:39.000Z
Jul 17, 2026
Trading halt
Trading Halt: APLM — LUDP (Volatility Trading Pause)
Apollomics Inc Class A Ord Shs | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Jul 9, 2026
Listing
Listing Status: APLM — Normal (was Deficient)
Apollomics Inc. - Class A Ordinary Shares | Nasdaq Financial Status Indicator D → N
Jun 24, 2026
Regulatory
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
FOSTER CITY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (“Apollomics” or the “Company”), a late-stage clinical…
Apr 27, 2026
Earnings
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
FOSTER CITY, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM), a clinical-stage biopharmaceutical company advancing…

Insider ledger

Form 4
$8.3M
bought · 3 insiders
$0
sold · 0 insiders
DateInsiderTypeValue
Sep 15, 2026
Chen Hung-Wen
Chief Executive Officer
EXERCISE5,000 sh
Sep 15, 2026
TSAI HSIEN-SHU
Director
EXERCISE500 sh
Sep 15, 2026
CHEN HONG-JUNG
Director
EXERCISE500 sh
Sep 15, 2026
Yen Hung Hsien
Director
EXERCISE500 sh
Sep 15, 2026
LIN PETER KUAN-HOW
Chief Financial Officer
TAX W/H$82.1K
Sep 15, 2026
LIN PETER KUAN-HOW
Chief Financial Officer
EXERCISE10,000 sh
Sep 15, 2026
Chen Yi-Kuei
Chief Operating Officer
EXERCISE5,000 sh
Sep 14, 2026
Chen Hung-Wen
Chief Executive Officer
AWARD8,000 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
5,730
shares short
+1.6%
vs prior settlement
1.0
days to cover
≈0.2%
of shares outstanding
Trading halts
Jul 17, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 15, 2026 Insider
Chen Hung-Wen acquired via exercise 5,000 shares
Chief Executive Officer
Sep 15, 2026 Insider
TSAI HSIEN-SHU acquired via exercise 500 shares
Director
Sep 15, 2026 Insider
CHEN HONG-JUNG acquired via exercise 500 shares
Director
Aug 17, 2026 SEC
Three C-suite insiders at Apollomics Inc. (APLM) collectively purchased $2.25M in open-market stock at $15.00/share…
CLUSTER — Impact 8/10
Aug 17, 2026 SEC
Three C-suite insiders at Apollomics Inc. (APLM) collectively purchased $2.25M of stock at $15.00/share over a 4-day…
CLUSTER — Impact 8/10
Aug 17, 2026 SEC
Three top executives at Apollomics (CEO, CFO, COO) collectively purchased $2.25M of APLM stock in open-market…
CLUSTER — Impact 8/10
Jul 17, 2026 Trading halt
Halt Resumed: APLM — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-07-17T13:47:39.000Z | Resumed 2026-07-17T13:52:39.000Z
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
2 shares ($42.00)

SecBot reports

8 filings · 6 bullish · 1 bearish · 1 neutral
All APLM filing & press-release reports (8)